Assessment of the treatment response of HCC

Abdominal Imaging

Volumn 36, Issue 3, 2011, Pages 300-314

  Kim, Kyung Won ^a   Lee, Jeong Min ^a   Choi, Byung Ihn ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Hepatocellular carcinoma; Liver tumors; Radiofrequency ablation; Sorafenib therapy; Transarterial embolization

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOXETIC ACID; IODINATED POPPYSEED OIL; SORAFENIB; YTTRIUM 90;

ABLATION THERAPY; ARTIFICIAL EMBOLISM; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; ETHANOL ABLATION; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; THERMAL INJURY; TRANSARTERIAL RADIOEMBOLIZATION; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; BENZENESULFONATES; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; CONTRAST MEDIA; ETHANOL; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MOLECULAR TARGETED THERAPY; PYRIDINES; TOMOGRAPHY, X-RAY COMPUTED; YTTRIUM RADIOISOTOPES;

EID: 79960321605     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-011-9683-3     Document Type: Review

References (53)

1. WY Lau EC Lai 2008 Hepatocellular carcinoma: current management and recent advances Hepatobiliary Pancreat Dis Int 7 237 257 18522878 (Pubitemid 351895383)
2. P Sauer TW Kraus P Schemmer, et al. 2005 Liver transplantation for hepatocellular carcinoma: is there evidence for expanding the selection criteria? Transplantation 80 S105 S108 16286885 10.1097/01.tp.0000187107.64215. 7b (Pubitemid 41552918)
3. B Rampone B Schiavone A Martino C Viviano G Confuorto 2009 Current management strategy of hepatocellular carcinoma World J Gastroenterol 15 3210 3216 19598295 10.3748/wjg.15.3210 1:CAS:528:DC%2BD1MXpsF2rurY%3D
4. WY Lau 1997 The history of liver surgery J R Coll Surg Edinb 42 303 309 9354061 1:STN:280:DyaK1c%2FhsFGltg%3D%3D (Pubitemid 27470366)
5. T Zhang X Ding D Wei, et al. 2010 Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trials Anticancer Drugs 21 326 332 20016366 10.1097/CAD.0b013e3283350e26 1:CAS:528:DC%2BC3cXhsVWitbY%3D
6. World Health Organization (WHO) (1979) WHO Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland: WHO. WHO Offset Publication No. 48
7. P Therasse SG Arbuck EA Eisenhauer, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216 10655437 10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D
8. EA Eisenhauer P Therasse J Bogaerts, et al. 2009 New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 228 247 19097774 10.1016/j.ejca.2008.10.026 1:STN:280: DC%2BD1M%2Fgs12rug%3D%3D
9. A Riaz FH Miller LM Kulik, et al. 2010 Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma JAMA 303 1062 1069 20233824 10.1001/jama.2010.262 1:CAS:528:DC%2BC3cXjsF2qs7k%3D
10. A Forner C Ayuso M Varela, et al. 2009 Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? Cancer 115 616 623 19117042 10.1002/cncr.24050
11. J Bruix M Sherman JM Llovet, et al. 2001 Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 421 430 11592607 10.1016/S0168-8278(01)00130-1 1:STN:280:DC%2BD3MrksFCmtg%3D%3D (Pubitemid 32844200)
12. VN Harry SI Semple DE Parkin FJ Gilbert 2010 Use of new imaging techniques to predict tumour response to therapy Lancet Oncol 11 92 102 20129132 10.1016/S1470-2045(09)70190-1
13. JA Vossen M Buijs IR Kamel 2006 Assessment of tumor response on MR imaging after locoregional therapy Tech Vasc Interv Radiol 9 125 132 17561215 10.1053/j.tvir.2007.02.004 (Pubitemid 46875018)
14. JS Yu JH Kim JJ Chung KW Kim 2009 Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas J Magn Reson Imaging 30 153 160 19557734 10.1002/jmri.21818
15. BJ Youn JW Chung KR Son, et al. 2008 Diffusion-weighted MR: therapeutic evaluation after chemoembolization of VX-2 carcinoma implanted in rabbit liver Acad Radiol 15 593 600 18423316 10.1016/j.acra.2007.10.022 (Pubitemid 351515890)
16. G Chen DQ Ma W He BF Zhang LQ Zhao 2008 Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma World J Gastroenterol 14 5738 5743 18837093 10.3748/wjg.14.5738
17. A Jackson H Haroon XP Zhu, et al. 2002 Breath-hold perfusion and permeability mapping of hepatic malignancies using magnetic resonance imaging and a first-pass leakage profile model NMR Biomed 15 164 173 11870912 10.1002/nbm.729 1:STN:280:DC%2BD387jsFamtQ%3D%3D (Pubitemid 34213406)
18. KW Kim JM Lee E Klotz, et al. 2009 Quantitative CT color mapping of the arterial enhancement fraction of the liver to detect hepatocellular carcinoma Radiology 250 425 434 19188314 10.1148/radiol.2501072196
19. BI Choi JM Lee 2009 Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments: imaging diagnosis and staging of hepatocellular carcinoma J Hepatobiliary Pancreat Sci 17 369 373 19967573 10.1007/s00534-009- 0227-y
20. HY Sun JM Lee CI Shin, et al. 2010 Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or = 2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging Invest Radiol 45 96 103 20057319 10.1097/RLI.0b013e3181c5faf7 1:CAS:528:DC%2BC3cXps1Sruw%3D%3D
21. JM Llovet MI Real X Montana, et al. 2002 Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 1734 1739 12049862 10.1016/S0140-6736(02)08649-X (Pubitemid 34607087)
22. CM Lo H Ngan WK Tso, et al. 2002 Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 1164 1171 11981766 10.1053/jhep.2002.33156 1:CAS:528:DC%2BD38XktF2hu7w%3D (Pubitemid 34454013)
23. HS Lee KM Kim JH Yoon, et al. 2002 Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study J Clin Oncol 20 4459 4465 12431969 10.1200/JCO.2002.02.013 (Pubitemid 35334758)
24. A Riaz RJ Lewandowski L Kulik, et al. 2010 Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization Cardiovasc Intervent Radiol 33 1143 1152 19967371 10.1007/s00270-009-9766-5
25. KM Jang D Choi HK Lim, et al. 2005 Depiction of viable tumor in hepatocellular carcinoma treated with transarterial chemoembolization: multiphasic helical CT with review of the previous serial CT images Korean J Radiol 6 153 160 16145290 10.3348/kjr.2005.6.3.153 (Pubitemid 41296874)
26. IR Kamel DA Bluemke J Eng, et al. 2006 The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma J Vasc Interv Radiol 17 505 512 16567675 10.1097/01.RVI.0000200052.02183.92 (Pubitemid 44318722)
27. Schima W, Ba-Ssalamah A, Kurtaran A, Schindl M, Gruenberger T (2007) Post-treatment imaging of liver tumours. Cancer Imaging 7 Spec No A:S28-S36 (Pubitemid 350143144)
28. IR Kamel DA Bluemke D Ramsey, et al. 2003 Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma AJR Am J Roentgenol 181 708 710 12933464 (Pubitemid 37021839)
29. S Goshima M Kanematsu H Kondo, et al. 2008 Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator? J Magn Reson Imaging 27 834 839 18383261 10.1002/jmri.21316 (Pubitemid 351508099)
30. SM Ibrahim P Nikolaidis FH Miller, et al. 2009 Radiologic findings following Y90 radioembolization for primary liver malignancies Abdom Imaging 34 566 581 18777189 10.1007/s00261-008-9454-y
31. VL Gates B Atassi RJ Lewandowski, et al. 2007 Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors Future Oncol 3 73 81 17280504 10.2217/14796694.3.1.73 1:CAS:528:DC%2BD2sXjtFCgsbc%3D
32. B Atassi AK Bangash A Bahrani, et al. 2008 Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay Radiographics 28 81 99 18203932 10.1148/rg.281065721
33. E Duke J Deng SM Ibrahim, et al. 2010 Agreement between competing imaging measures of response of hepatocellular carcinoma to yttrium-90 radioembolization J Vasc Interv Radiol 21 515 521 20172741 10.1016/j.jvir.2009. 11.020
34. R Salem RJ Lewandowski MF Mulcahy, et al. 2010 Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes Gastroenterology 138 52 64 19766639 10.1053/j.gastro.2009. 09.006 1:CAS:528:DC%2BC3cXht1ajsLY%3D
35. TK Rhee NK Naik J Deng, et al. 2008 Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging J Vasc Interv Radiol 19 1180 1186 18656011 10.1016/j.jvir.2008.05.002
36. DA Gervais S Kalva A Thabet 2009 Percutaneous image-guided therapy of intra-abdominal malignancy: imaging evaluation of treatment response Abdom Imaging 34 593 609 19015913 10.1007/s00261-008-9473-8
37. Rhim H, Goldberg SN, Dodd GD III, et al. (2001) Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors. Radiographics 21 Spec No:S17-S35; discussion S36-S19 (Pubitemid 33706955)
38. SN Goldberg GS Gazelle CC Compton PR Mueller KK Tanabe 2000 Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation Cancer 88 2452 2463 10861420 10.1002/1097-0142(20000601)88: 11<2452::AID-CNCR5>3.0.CO;2-3 1:STN:280:DC%2BD3cvisFyksg%3D%3D (Pubitemid 30331950)
39. HK Lim D Choi WJ Lee, et al. 2001 Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT Radiology 221 447 454 11687689 10.1148/radiol.2212010446 1:STN:280:DC%2BD3MnjvFCntg%3D%3D (Pubitemid 33043430)
40. C Dromain T de Baere D Elias, et al. 2002 Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up Radiology 223 255 262 11930075 10.1148/radiol.2231010780 (Pubitemid 34258217)
41. SN Goldberg CJ Grassi JF Cardella, et al. 2009 Image-guided tumor ablation: standardization of terminology and reporting criteria J Vasc Interv Radiol 20 S377 S390 19560026 10.1016/j.jvir.2009.04.011
42. MH Park H Rhim YS Kim, et al. 2008 Spectrum of CT findings after radiofrequency ablation of hepatic tumors Radiographics 28 379 390 18349446 10.1148/rg.282075038 discussion 390-372
43. E Ozkavukcu N Haliloglu A Erden 2009 Post-treatment MRI findings of hepatocellular carcinoma Diagn Interv Radiol 15 111 120 19517381
44. S Chopra GD Dodd III KN Chintapalli, et al. 2001 Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT AJR Am J Roentgenol 177 381 387 11461868 1:STN:280:DC%2BD3MvktVCrtw%3D%3D (Pubitemid 32660499)
45. L Assumpcao M Choti TM Pawlik JF Gecshwind IR Kamel 2009 Functional MR imaging as a new paradigm for image guidance Abdom Imaging 34 675 685 19048335 10.1007/s00261-008-9481-8
46. C Schraml NF Schwenzer S Clasen, et al. 2009 Navigator respiratory-triggered diffusion-weighted imaging in the follow-up after hepatic radiofrequency ablation-initial results J Magn Reson Imaging 29 1308 1316 19418557 10.1002/jmri.21770
47. LF Pupulim A Hakime V Barrau, et al. 2009 Fatty hepatocellular carcinoma: radiofrequency ablation-imaging findings Radiology 250 940 948 19164699 10.1148/radiol.2502080858
48. YK Cho JK Kim MY Kim H Rhim JK Han 2009 Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies Hepatology 49 453 459 19065676 10.1002/hep.22648
49. S Sironi F De Cobelli T Livraghi, et al. 1994 Small hepatocellular carcinoma treated with percutaneous ethanol injection: unenhanced and gadolinium-enhanced MR imaging follow-up Radiology 192 407 412 8029405 1:STN:280:DyaK2czgt1ahtA%3D%3D (Pubitemid 24233918)
50. M Ebara K Kita N Sugiura, et al. 1995 Therapeutic effect of percutaneous ethanol injection on small hepatocellular carcinoma: evaluation with CT Radiology 195 371 377 7536946 1:STN:280:DyaK2M3ktFOjug%3D%3D
51. L Rimassa A Santoro 2009 Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial Expert Rev Anticancer Ther 9 739 745 19496710 10.1586/era.09.41 1:CAS:528:DC%2BD1MXmvFaguro%3D
52. M Horger UM Lauer C Schraml, et al. 2009 Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib BMC Cancer 9 208 19558720 10.1186/1471-2407-9- 208
53. O Maksimovic C Schraml JT Hartmann, et al. 2010 Evaluation of response in malignant tumors treated with the multitargeted tyrosine kinase inhibitor sorafenib: a multitechnique imaging assessment AJR Am J Roentgenol 194 5 14 20028898 10.2214/AJR.09.2744